phenobarbital has been researched along with dobutamine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Daicho, T; Kawahara, Y; Nasa, Y; Nawa, M; Oikawa, R; Takeo, S; Tanonaka, K | 1 |
Agarwal, R; Deorari, AK; Jain, A; Paul, VK | 1 |
1 review(s) available for phenobarbital and dobutamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for phenobarbital and dobutamine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preferable anesthetic conditions for echocardiographic determination of murine cardiac function.
Topics: Adrenergic beta-Agonists; Anesthetics; Animals; Cardiac Output; Dobutamine; Drug Combinations; Echocardiography, Doppler, Color; Heart Rate; Ketamine; Male; Mice; Mice, Inbred C57BL; Phenobarbital; Rats; Rats, Wistar; Ventricular Function; Xylazine | 2005 |
Post-resuscitation management of asphyxiated neonates.
Topics: Anticonvulsants; Asphyxia Neonatorum; Calcium; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Electroencephalography; Fluid Therapy; Humans; Hypoxia-Ischemia, Brain; Incubators, Infant; Infant, Newborn; Intensive Care, Neonatal; Monitoring, Physiologic; Oxygen; Phenobarbital; Respiration, Artificial; Treatment Outcome | 2008 |